» Articles » PMID: 29859750

Novel Leucine Ureido Derivatives As Aminopeptidase N Inhibitors Using Click Chemistry

Overview
Journal Bioorg Med Chem
Specialties Biochemistry
Chemistry
Date 2018 Jun 4
PMID 29859750
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The over-expression of aminopeptidase N on diverse malignant cells is associated with the tumor angiogenesis and metastasis. In this report, one new series of leucine ureido derivatives containing the triazole moiety was designed, synthesized and evaluated as APN inhibitors. Among them, compound 13v showed the best APN inhibition with an IC value of 0.089 ± 0.007 μM, which was two orders of magnitude lower than that of bestatin (IC = 9.4 ± 0.5 μM). Compound 13v also showed dose-dependent anti-angiogenesis activities. Even at the lower concentration (10 μM), compound 13v presented similar anti-angiogenesis activity compared with bestatin at 100 μM in both the human umbilical vein endothelial cells (HUVECs) capillary tube formation assay and the rat thoracic aorta rings test. Moreover, compared with bestatin, 13v exhibited comparable, if not better in vivo anti-metastasis activity in a mouse H22 pulmonary metastasis model.

Citing Articles

Synthesis, biological and pharmacokinetic characterization of a novel leucine ureido derivative as a multi-target anticancer agent.

Shi F, Xu Q, Zhang Y, Cao J, Liu C, Liu A RSC Adv. 2025; 15(6):4348-4355.

PMID: 39931415 PMC: 11808297. DOI: 10.1039/d4ra03200d.


Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors.

Liu Q, Dong H, Zhao W, Zhang G, Li S, Xu Q ACS Med Chem Lett. 2021; 12(12):1932-1941.

PMID: 34917257 PMC: 8667313. DOI: 10.1021/acsmedchemlett.1c00504.


1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.

Bozorov K, Zhao J, Aisa H Bioorg Med Chem. 2019; 27(16):3511-3531.

PMID: 31300317 PMC: 7185471. DOI: 10.1016/j.bmc.2019.07.005.